Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).
Símbolo de cotizaciónAKYA
Nombre de la empresaAkoya Biosciences Inc
Fecha de salida a bolsaApr 16, 2021
Director ejecutivoMr. Brian Mckelligon
Número de empleados205
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 16
Dirección100 Campus Drive
CiudadMARLBOROUGH
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal01762
Teléfono18558968401
Sitio Webhttps://www.akoyabio.com/
Símbolo de cotizaciónAKYA
Fecha de salida a bolsaApr 16, 2021
Director ejecutivoMr. Brian Mckelligon
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos